USTR sets hearing in Section 301 probe of Germany pharma pricing
USTR announced a public hearing for September 22, 2026 in its Section 301 investigation of Germany's acts, policies, and practices tied to persistent underpayment for innovative pharmaceutical products. The notice is procedural and does not announce tariffs or other remedies.
What this affects
GermanyThe update
USTR announced that it will hold a public hearing on September 22, 2026 regarding its Section 301 investigation into Germany's acts, policies, and practices related to the persistent underpayment for innovative pharmaceutical products. The document is a press release about the hearing.
The action sits within a Section 301 investigation, which means the matter remains under review rather than implemented as a tariff change. The scope identified in the release is Germany and innovative pharmaceutical products.
The release does not state any duty rate, effective tariff date, or product list for imports. It also does not announce a final determination or any trade measure.
Impact
For importers, this document signals that a live Section 301 case could affect future costs or sourcing for products tied to the investigation's scope, but it does not change current duty liability. Finance and sourcing teams may still want to monitor the case because Section 301 proceedings can lead to added compliance and landed cost changes later.
What to watch
A hearing notice is not a tariff action. The press release does not identify any tariff rate, HTS coverage, or implementation details, so it is easy to overread this as an immediate import cost change when it is only a procedural step in an ongoing investigation.
How to prepare
- 1Map affected pharmaceutical imports
Identify shipments and suppliers that could fall within the investigation's product scope.
- 2Review origin documentation
Confirm records that support country of origin for relevant products.
- 3Model possible landed cost changes
Run scenarios so finance teams can gauge exposure if duties are later announced.
- 4Monitor USTR case updates
Track hearing materials and later notices for any scope or remedy details.
Sources
- Public Hearing Regarding Section 301 Investigation of Germany’s Persistent Underpayment for Innovative Pharmaceutical Products · USTR · September 21, 2026
- Our New Amicus Brief in the Section 301 Tariff Case · Reason Magazine · September 14, 2026
- In re Section 301 Forced Labor Cases · Cato Institute · September 17, 2026
- Former Top US Trade Officials Say Trump’s Section 301 Tariffs Are Illegal · WWD · September 16, 2026
We summarize published reporting and official notices. Always confirm rates and dates against the Federal Register or your customs broker before acting on them.